{"id":"9d4d01ee3133","type":"article","url":"https://hartvaat.nl/2017/09/26/sams-ci-score-toegepast-op-gerandomiseerde-trial-over-statine-myopathie/","title":"SAMS-CI score toegepast op gerandomiseerde trial over statine-myopathie","title_en":"Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Randomized Trial on Statin Myopathy.","category":"cholesterol","category_label":"Cholesterol","professions":["apotheker","cardioloog"],"tags":[],"journal":"Journal of the American College of Cardiology","doi":"10.1016/j.jacc.2017.07.767","source_url":"https://doi.org/10.1016/j.jacc.2017.07.767","authors":["Beth A Taylor","Robert J Sanchez","Terry A Jacobson","Daniela Chibedi-De-Roche","Garen Manvelian","Marie T Baccara-Dinet","Irfan Khan","Robert S Rosenson"],"significance":6,"published":"2017-09-26","source_date":"2017-09-26","image":"","kennis":["https://hartvaat.nl/kennis/preventie/statines-primaire-preventie/","https://hartvaat.nl/kennis/lipiden/familiaire-hypercholesterolemie/"],"congress":"","summary_en":"This study applied the Statin-Associated Muscle Symptoms Clinical Index (SAMS-CI) to a randomized trial, refining the diagnostic approach for distinguishing true statin myopathy from nocebo-driven symptom reporting.","created":"2026-07-03T10:26:54Z","updated":"2026-07-03T13:26:11Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Toepassing van de Statin-Associated Muscle Symptoms-Clinical Index (SAMS-CI) op een gerandomiseerde trial. Verfijnt de diagnostiek van statinegerelateerde spierklachten.","abstract_original":""}